KR102577838B1 - 로피니롤 함유 첩부제 및 로피니롤의 피부 투과성 향상 방법 - Google Patents

로피니롤 함유 첩부제 및 로피니롤의 피부 투과성 향상 방법 Download PDF

Info

Publication number
KR102577838B1
KR102577838B1 KR1020237016598A KR20237016598A KR102577838B1 KR 102577838 B1 KR102577838 B1 KR 102577838B1 KR 1020237016598 A KR1020237016598 A KR 1020237016598A KR 20237016598 A KR20237016598 A KR 20237016598A KR 102577838 B1 KR102577838 B1 KR 102577838B1
Authority
KR
South Korea
Prior art keywords
ropinirole
adhesive layer
sodium
group
patch
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020237016598A
Other languages
English (en)
Korean (ko)
Other versions
KR20230088789A (ko
Inventor
나오유키 우치다
사토시 아마노
Original Assignee
히사미쓰 세이야꾸 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 히사미쓰 세이야꾸 가부시키가이샤 filed Critical 히사미쓰 세이야꾸 가부시키가이샤
Publication of KR20230088789A publication Critical patent/KR20230088789A/ko
Application granted granted Critical
Publication of KR102577838B1 publication Critical patent/KR102577838B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020237016598A 2020-10-29 2021-10-21 로피니롤 함유 첩부제 및 로피니롤의 피부 투과성 향상 방법 Active KR102577838B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JPJP-P-2020-181280 2020-10-29
JP2020181280 2020-10-29
PCT/JP2021/038892 WO2022091925A1 (ja) 2020-10-29 2021-10-21 ロピニロール含有貼付剤及びロピニロールの皮膚透過性向上方法

Publications (2)

Publication Number Publication Date
KR20230088789A KR20230088789A (ko) 2023-06-20
KR102577838B1 true KR102577838B1 (ko) 2023-09-12

Family

ID=81382322

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020237016598A Active KR102577838B1 (ko) 2020-10-29 2021-10-21 로피니롤 함유 첩부제 및 로피니롤의 피부 투과성 향상 방법

Country Status (8)

Country Link
US (1) US12440452B2 (https=)
EP (1) EP4238563B1 (https=)
JP (1) JP7284877B2 (https=)
KR (1) KR102577838B1 (https=)
CN (1) CN116322658B (https=)
ES (1) ES3049508T3 (https=)
TW (1) TWI821765B (https=)
WO (1) WO2022091925A1 (https=)

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5872111A (en) * 1997-05-19 1999-02-16 Lever Brothers Company, Division Of Conopco, Inc. Compositions comprising glycosylamide surfactants
DE10137162A1 (de) * 2001-07-30 2003-02-20 Hexal Ag Matrixkontrolliertes transdermales therapeutisches System zur Anwendung von Pramiprexol und Ropinirol
JP5546013B2 (ja) * 2008-02-27 2014-07-09 久光製薬株式会社 貼付剤及び包装体
EP2258369B1 (en) 2008-02-27 2015-04-08 Hisamitsu Pharmaceutical Co., Inc. Medicated patch
ES2513691T3 (es) 2009-05-21 2014-10-27 Hisamitsu Pharmaceutical Co., Inc. Preparación transdérmica
JP5631854B2 (ja) * 2010-12-13 2014-11-26 久光製薬株式会社 医薬組成物および貼付剤
WO2012165253A1 (ja) 2011-05-31 2012-12-06 久光製薬株式会社 ロピニロール含有貼付剤及びその包装体
KR101848961B1 (ko) 2011-05-31 2018-04-13 히사미쓰 세이야꾸 가부시키가이샤 로피니롤 함유 첩부제 및 그 포장체
EP2786752B1 (en) * 2011-12-01 2019-06-12 Teikoku Seiyaku Co., Ltd. Ropinirole-containing adhesive patch
AU2013305563B2 (en) * 2012-08-24 2018-09-27 Integurx Therapeutics, Llc Chemical compositions and methods for enhancing transdermal delivery of therapeutic agents
CA2924233C (en) * 2013-10-07 2018-10-23 Teikoku Pharma Usa, Inc. Methods and compositions for treating attention deficit hyperactivity disorder, anxiety and insomnia using dexmedetomidine transdermal compositions
US10449254B2 (en) * 2013-11-03 2019-10-22 The Regents Of The University Of California Ionic liquids for transdermal drug delivery
JP6373061B2 (ja) * 2014-05-23 2018-08-15 帝國製薬株式会社 経皮投与製剤
WO2017037812A1 (ja) * 2015-08-29 2017-03-09 株式会社メドレックス 酸捕捉剤を含有する貼付製剤
MX389514B (es) * 2015-10-01 2025-03-20 Firmenich Incorporated Compuestos útiles como moduladores de canal receptor 8 de potencial transitorio de melastatina (trpm8).
EP3586841B1 (en) * 2017-02-24 2023-12-27 Hisamitsu Pharmaceutical Co., Inc. Adhesive skin patch and packaged product thereof
TWI825013B (zh) * 2017-04-19 2023-12-11 日商帝國製藥股份有限公司 含有盧帕他定（ｒｕｐａｔａｄｉｎｅ）之貼附劑
CN107375249A (zh) * 2017-07-26 2017-11-24 徐静 一种含罗匹尼罗的缓释透皮贴剂及其应用
US20200297654A1 (en) * 2017-10-17 2020-09-24 Lubrizol Advanced Materials, Inc. Composition and device for delivery of active agents to skin surfaces

Also Published As

Publication number Publication date
EP4238563A4 (en) 2024-10-02
TW202227052A (zh) 2022-07-16
JP7284877B2 (ja) 2023-05-31
JPWO2022091925A1 (https=) 2022-05-05
ES3049508T3 (en) 2025-12-17
CN116322658A (zh) 2023-06-23
CN116322658B (zh) 2025-09-26
WO2022091925A1 (ja) 2022-05-05
EP4238563A1 (en) 2023-09-06
EP4238563B1 (en) 2025-09-24
US20240016758A1 (en) 2024-01-18
TWI821765B (zh) 2023-11-11
KR20230088789A (ko) 2023-06-20
US12440452B2 (en) 2025-10-14

Similar Documents

Publication Publication Date Title
JP7716603B2 (ja) ロチゴチン含有貼付剤及びロチゴチン安定性向上方法
JP6689443B2 (ja) 貼付剤及びその包装体
JPWO2018198925A1 (ja) 貼付剤
KR102453715B1 (ko) 로피니롤 함유 첩부제 및 로피니롤의 피부 투과성 향상 방법
KR102577838B1 (ko) 로피니롤 함유 첩부제 및 로피니롤의 피부 투과성 향상 방법
TW202341980A (zh) 含羅替戈汀之貼附劑
JP7202450B2 (ja) ロピニロール含有貼付剤の粘着剤層保持力向上方法、及びロピニロール含有保持力改善貼付剤
CN110545816B (zh) 贴附剂

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20230516

Patent event code: PA01051R01D

Comment text: International Patent Application

PA0201 Request for examination
A302 Request for accelerated examination
PA0302 Request for accelerated examination

Patent event date: 20230609

Patent event code: PA03022R01D

Comment text: Request for Accelerated Examination

PG1501 Laying open of application
E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20230714

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20230908

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20230908

End annual number: 3

Start annual number: 1

PG1601 Publication of registration